Capital Investment Advisors, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital Investment Advisors, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$364,904
+15.7%
40,5900.0%0.01%0.0%
Q3 2023$315,384
-19.7%
40,5900.0%0.01%
-25.0%
Q2 2023$392,911
-11.2%
40,590
+0.6%
0.01%
-7.7%
Q1 2023$442,400
+254152.9%
40,3650.0%0.01%
+160.0%
Q4 2022$174
-99.9%
40,365
+32.9%
0.01%
-37.5%
Q3 2022$228,000
-23.2%
30,365
+2.7%
0.01%
-20.0%
Q2 2022$297,000
-16.8%
29,565
+2.5%
0.01%
-9.1%
Q1 2022$357,000
+4.1%
28,840
+92.3%
0.01%
+10.0%
Q4 2021$343,000
+19.1%
15,000
+15.4%
0.01%0.0%
Q3 2021$288,000
+121.5%
13,000
+30.0%
0.01%
+150.0%
Q2 2021$130,00010,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders